Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
American Journal of Human Genetics|October 24, 2017
A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene ExpressionMichael D Gallagher, Marijan Posavi, Peng Huang, et al.
Annals of Neurology|May 20, 2022
Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's DiseaseJunchao Shen, Noor Amari, Rebecca Zack, et al.
Access Microbiology|November 16, 2023
Determining the impact of vaccination on SARS-CoV-2 RT-PCR cycle threshold values and infectious viral titresKatherine L Peterson, Julia P Snyder, Hannah W Despres, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 18, 2014
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeChristine R Swanson, Katherine Li, Travis L Unger, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodiesMarc Carceles-Cordon, Eliza M Brody, Masen L Boucher, et al.
Neuron|May 13, 2026
Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodiesMarc Carceles-Cordon, Eliza M Brody, Masen L Boucher, et al.
Nature Genetics|January 11, 2011
Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunityEkkehart Lausch, Andreas Janecke, Matthias Bros, et al.
Lupus|September 24, 2013
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)M Witt, M Grunke, F Proft, et al.
Zeitschrift Fur Rheumatologie|June 8, 2017
[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]F Proft, H Schulze-Koops, M Grunke, et al.
Science (New York, N.Y.)|August 18, 2022
GPNMB confers risk for Parkinson's disease through interaction with α-synucleinMaria E Diaz-Ortiz, Yunji Seo, Marijan Posavi, et al.
Pageof 21